SCHEMBL3943201

SCHEMBL3943201

Cc1ncc(N)cc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30154986 0.79
SCHEMBL762583 0.79
SCHEMBL28300406 0.79 NOS3 (0.52)
SCHEMBL94027 0.79
Hydrochloric Acid SCHEMBL4046885 0.77 NOS3 (0.41)
Hydrochloric Acid SCHEMBL27623348 0.77 NOS3 (0.41)
SCHEMBL3585029 0.77
SCHEMBL3354990 0.75
SCHEMBL111804 0.75
SCHEMBL7878469 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023111005-A1 CARBOXAMIDE SUBSTITUTED HETEROAROMATIC COMPOUNDS FOR TREATING CANCER WMT AG (DE) 2023-06-22 WO disclosed
WO-2023111005-A1 CARBOXAMIDE SUBSTITUTED HETEROAROMATIC COMPOUNDS FOR TREATING CANCER WMT AG (DE) 2023-06-22 WO disclosed
WO-2022060094-A1 PYRIMIDOPYRIMIDINONE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 엑세쏘바이오파마 2022-03-24 WO disclosed
EP-1831198-B1 PYRIDINE CARBOXAMIDE DERIVATIVES FOR USE AS ANTICANCER AGENTS ASTRAZENECA AB (SE) 2009-04-08 EP disclosed